Coya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension Phase

Key Takeaway: Coya Therapeutics has announced that the first cohort of patients in the ALSTARS trial has commenced the blinded active-treatment extension phase. This marks a significant step in the trial process, although specific details about patient outcomes or trial objectives were not disclosed. The announcement indicates progress in the clinical trial's timeline.